Predictors and Outcomes in Patients With Sickle Cell Disease

Completed

Conditions studied: Sickle Cell Disease

In brief

Children with sickle cell disease (SCD) are living longer with the advent of medical advances such as prophylactic penicillin, chronic transfusion, and hydroxyurea. Despite greater longevity in SCD, the period following the transition from pediatric to adult care is critical; youth aged 18-30 years are at high risk for mortality and have high rates of healthcare utilization, leading to high healthcare costs. As such, health care transition (HCT) programs have been created to prepare patients for adult-centered care and subsequently, improve health outcomes. However, very few programs have been evaluated for effectiveness in achieving optimal health outcomes in SCD. This paucity of program evaluation is attributed to a lack of identifiable predictors and outcomes. Researchers at St. Jude Children's Research Hospital want to identify factors and patterns of successful HCT. This information will be used to develop approaches to best evaluate HCT interventions and identify areas of improvement of HCT programming. PRIMARY OBJECTIVE: Describe hospital utilization, treatment adherence, and health-related quality of life in a cohort of patients with sickle cell disease (SCD) who will transfer to adult care during the study period. SECONDARY OBJECTIVE: Examine the associations between various factors and health care transition (HCT) outcomes.

Key facts

Study ID

NCT03431935

Run by

St. Jude Children's Research Hospital

People needed

94

Starts

2018-07-31

Expected to finish

2023-05-26

Last updated by the study team

2026-02-06

Who can join

Age: 16 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of sickle cell disease (all genotypes).
• Age 16.0 - 20.99 years at initial assessment.
• Primary language is English.

You may not qualify if…

• Participant unable to complete the questionnaires due to refusal, current acute illness (e.g., pain crisis), or significant cognitive impairment as judged by health care providers at the SCD clinic.
• Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.

Where it is running

• Methodist Adult Comprehensive Sickle Cell Center — Memphis, Tennessee, United States
• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.